FUSILEV Trademark

Trademark Overview

On Friday, March 7, 2008, a trademark application was filed for FUSILEV with the United States Patent and Trademark Office. The USPTO has given the FUSILEV trademark a serial number of 77415998. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Wednesday, March 18, 2020. This trademark is owned by Spectrum Pharmaceuticals, Inc.. The FUSILEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications
fusilev

General Information

Serial Number77415998
Word MarkFUSILEV
Filing DateFriday, March 7, 2008
Status710 - CANCELLED - SECTION 8
Status DateWednesday, March 18, 2020
Registration Number3667433
Registration DateTuesday, August 11, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications
Translation of Words in MarkThe wording "FUSILEV" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateWednesday, March 18, 2020
Primary Code005
First Use Anywhere DateFriday, August 15, 2008
First Use In Commerce DateFriday, August 15, 2008

Trademark Owner History

Party NameACROTECH BIOPHARMA LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressEAST WINDSOR, NJ 08520
Party NameSpectrum Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSpectrum Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSpectrum Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Thursday, March 19, 2020NOTICE OF CANCELLATION SEC. 8 EMAILED
Wednesday, March 18, 2020CANCELLED SEC. 8 (10-YR)
Monday, September 16, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, September 13, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 1, 2019TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 5, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, August 11, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 28, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 28, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 28, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 29, 2015TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 20, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 3, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 11, 2009REGISTERED-PRINCIPAL REGISTER
Monday, July 6, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, July 4, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 30, 2009STATEMENT OF USE PROCESSING COMPLETE
Monday, June 29, 2009USE AMENDMENT FILED
Monday, June 29, 2009TEAS STATEMENT OF USE RECEIVED
Friday, May 15, 2009EXTENSION 1 GRANTED
Tuesday, April 28, 2009EXTENSION 1 FILED
Friday, May 15, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 28, 2009TEAS EXTENSION RECEIVED
Tuesday, October 28, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 5, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 16, 2008NOTICE OF PUBLICATION
Wednesday, July 2, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 1, 2008ASSIGNED TO LIE
Tuesday, July 1, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 24, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 23, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 23, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 13, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2008NON-FINAL ACTION E-MAILED
Tuesday, May 13, 2008NON-FINAL ACTION WRITTEN
Tuesday, May 13, 2008ASSIGNED TO EXAMINER
Wednesday, March 12, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

fusilev folic methotrexate antagonists acid overdosage osteosarcoma indications colorectal inadvertent impaired